MedPath

Treatment of M.Graves With Radioactive Iodine: Follow-up Study

Conditions
Hyperthyroidism
Registration Number
NCT00525122
Lead Sponsor
Medisch Centrum Rijnmond-Zuid, Netherlands
Brief Summary

Hypothesis: What is the natural course after treatment with radioactive iodine in patients with hyperthyroidism?

What are the determinants for the development of acute hypo- or hyperthyroidism after treatment with radioactive iodine without antithyroid drugs?

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients wth hyperthyroidism who are eligible for treatment with radioactive iodine
  • Age > 18 years
Exclusion Criteria
  • Severe ophthalmopathy
  • Pregnancy or wish to pregnancy on short term
  • Breastfeeding
  • Patients already treated with radioactive iodine
  • Known cardiovascular diseases or other severe comorbidity

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

MCRZ

🇳🇱

Rotterdam, Zuid-Holland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath